Oxandrolone
Vérifier sur isomerdesign
Oxandrolone
Vérifier sur pubchem
Oxandrolone
Vérifier sur drugmap
Data
InChI: InChI=1S/C19H30O3/c1-17-11-22-16(20)10-12(17)4-5-13-14(17)6-8-18(2)15(13)7-9-19(18,3)21/h12-15,21H,4-11H2,1-3H3
Synonymes: Oxandrolone (JAN/USP/INN),OXANDROLONE [MI],2-Oxaandrostan-3-one, 17-hydroxy-17-methyl-, (5-alpha,17-beta)-,Oxandrolone, >=98% (HPLC),2-Oxaandrostan-3-one, 17-hydroxy-17-methyl-, (5.alpha.,17.beta.)-,OXANDROLONE [USP MONOGRAPH],AC-14975, Dodecahydro-3-hydroxy-6-(hydroxy-methyl)-3,3a,6-trimethyl-1H-benz(e)indene-7-acetic acid delta-lactone,D00462, SC-11585,OXANDROLONE [USAN],8075 CB,HY-B0707,CHEMBL1200436,Provitar,Dodecahydro-3-hydroxy-6-(hydroxy-methyl)-3,3a,6-trimethyl-1H-benz(e)indene-7-acetic acid delta-lactone,Oxandrolone,Oxandrolonum [INN-Latin],8075 C. B., (1S,3aS,3bR,5aS,9aS,9bS,11aS)-1-hydroxy-1,9a,11a-trimethyl-2,3,3a,3b,4,5,5a,6,9,9b,10,11-dodecahydroindeno[4,5-h]isochromen-7-one,17α-Methyl-2-oxa-4,5α-dihydrotestosterone,OXANDROLONE [ORANGE BOOK], SC 11585,2-Oxa-5alpha-androstan-3-one, 17beta-hydroxy-17-methyl-,SR-01000872645,7H6TM3CT4L,53-39-4,SC 11585,17beta-Hydroxy-17-methyl-2-oxa-5alpha-androstan-3-one,Ossandrolone [DCIT],DB00621, Oxandrolonum [INN-Latin],Oxandrolona [INN-Spanish],CHEBI:7820,17alpha-Methyl-17beta-hydroxy-2-oxa-5alpha-androstan-3-one, Anavar (TN),Protivar,17-beta-hydroxy-17-methyl-2-oxa-androstan-3-one,OXANDROLONE,Oxandrolone ciii,SC-11585, Ossandrolone [DCIT],Oxandrolone [USAN:USP:INN:BAN:JAN],UNII-7H6TM3CT4L,C07346,AKOS025401400, Lonavar,17α-Methyl-2-oxa-5α-androstan-17β-ol-3-one,OXANDROLONE [VANDF],NSC 67068,(4aS,4bS,6aS,7S,9aS,9bR,11aS)-7-hydroxy-4a,6a,7-trimethyltetradecahydroindeno[4,5-h]isochromen-2(1H)-one,GTPL7092, Provitar,Lonavar, Ossandrolone,OXANDROLONE CIII [USP-RS], Oxandrolone [USAN:INN:BAN:JAN], Oxandrolona [INN-Spanish],HSDB 3373, Vasorome,AB01559948-01, Oxandrin, Anavar, Oxandrolone,Oxandrolone (JAN/USP/INN), 2-Oxa-5alpha-androstan-3-one, 17beta-hydroxy-17-methyl-(8CI), Oxandrin,(1S,2S,7S,10R,11S,14S,15S)-14-hydroxy-2,14,15-trimethyl-4-oxatetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-5-one, 17-beta-hydroxy-17-methyl-2-oxa-androstan-3-one,Oxandrin,ZINC3813047,(1S,3aS,3bR,5aS,9aS,9bS,11aS)-1-hydroxy-1,9a,11a-trimethyl-2,3,3a,3b,4,5,5a,6,9,9b,10,11-dodecahydroindeno[4,5-h]isochromen-7-one,Oxandrin;Anavar,2-Oxa-5-alpha-androstan-3-one, 17-beta-hydroxy-17-methyl-, 17beta-Hydroxy-17-methyl-2-oxa-5alpha-androstan-3-one,OXANDROLONE [HSDB],OXANDROLONE [MART.],198O944,8075 C.B.,SCHEMBL148881,DTXSID8023399,CCG-220110, Oxandrolona, Protivar,NSC-67068,Anavar,Ossandrolone,SR-01000872645-1,Oxandrin (TN),OXANDROLONE [WHO-DD],W-105740, Oxandrin (TN),HMS3712E22,Oxandrolona, 17-beta-hydroxy-17-methyl-2-oxa-androstan-3-one (9CI), 2-Oxaandrostan-3-one, 17-hydroxy-17-methyl-, (5-alpha,17-beta)-(9CI),EINECS 200-172-9,OXANDROLONE [INN], 17beta-Hydroxy-17alpha-methyl-2-oxa-5alpha-androstan-3-one, Oxandrolonum, (4aS,4bS,6aS,7S,9aS,9bR,11aS)-7-hydroxy-4a,6a,7-trimethyltetradecahydroindeno[4,5-h]isochromen-2(1H)-one,Q420859,17beta-Hydroxy-17alpha-methyl-2-oxa-5alpha-androstan-3-one,Oxandrolonum,OXANDROLONE [JAN],2-Oxaandrostan-3-one, 17-hydroxy-17-methyl-, (5alpha,17beta)-,Vasorome
Estimated data
Solubility: -4.503 (log(S) in mol/L prediction using SolTranNet)
Blood Brain Barrier Permeability: No (prediction using frontiersin.org)
Addictivity Prediction: 64.5% (prediction based on www.mdpi.com)
